Investigating bioactive potential of the Serratia sp. CS01 and its pigment for anti-inflammatory, antioxidant and antibacterial action Authors: Anju Kanjirakandi Ashokan, Amarthya Suresh, Nandha Kumar Selvanathan, Prerana Sanjay Shankpal, Bhargawi Rajendra Apte, Subathra Devi Chandrasekaran, Ramanathan Karuppasamy, Sudarshana Deepa Vijayakumar, Mohanasrinivasan Vaithilingam Published: 2026 ABSTRACT AbstractMicrobial proteases and pigments contain biomolecular properties with considerable therapeutic and industrial applications. In the present investigation, a bacterial isolate named CS01 was taxonomically identified as Serratia sp., utilizing 16S rDNA sequencing. HPLC, MALDI-TOF analysis and SDS-PAGE (~ 60 kDa band) shows the presence of an anti-inflammatory protease. In addition, a red pigment was extracted from the isolate and identified as prodigiosin-like pigment, confirmed through UV–Vis spectrophotometry, FTIR, HPLC and HRMS analysis. The cell free supernatant showed Human red blood cell membrane stabilization of 79.3 ± 0.007%, while the pigment extract showed high stability of 95.33 ± 0.004%. The heat-induced haemolysis revealed 87.18 ± 0.003% of membrane protection for the cell free supernatant 95.57 ± 0.005% for pigment sample, showing comparable efficacy to that of diclofenac (94.37 ± 0.003%). The crude and pigment sample from CS01 also showed the ability to inhibit egg albumin denaturation with a range of 80.31 ± 0.01% and 85.6 ± 0.005%. In addition, Serratia sp. CS01 exhibited 55.93 ± 0.008% of antioxidant activity and its pigment showed 91.26 ± 0.28% at 1000 µg/mL. Antibacterial studies revealed the ability of the strain to inhibit the growth of Escherichia coli, Bacillus cereus, and Staphylococcus aureus. The MIC results for the pigment sample exhibited higher antibacterial efficacy in comparison to the crude extract, attaining inhibition rates nearing 90% within a concentration spectrum (10–150 µg/mL). Collectively, these results summarize that Serratia sp. CS01 simultaneously produces both anti-inflammatory protease and prodigiosin-like pigment having anti-inflammatory, antioxidant, and antibacterial properties. This highlights Serratia sp. CS01 as a promising microbial source of multifunctional biomolecules with prospective therapeutic and industrial applications.Supplementary InformationThe online version contains supplementary material available at https://doi.org/10.1038/s41598-026-56314-x.Keywords: Anti-inflammatory protease, Prodigiosin, Serratia sp., Therapeutic enzymeSubject terms: Biochemistry, Biological techniques, Biotechnology, Microbiology Introduction The world is shifting to sustainable microbial derived therapeutic agents over the growing concern and adverse effects of synthetic drugs in therapeutic and industrial applications. Studies shows that microbial enzymes have acquired significant attention for their possible clinical roles and lesser risks compared to conventional anti-inflammatory agents like non-steroidal anti-inflammatory drugs1. Recent innovations in immunology and biotechnology suggest that bacterial proteases could be a substantial selection alongside conventional anti-inflammatory methods. The deliberate degradation of inflammatory agents by bacterial proteases helps in clearing out apoptotic cells, thereby supporting immune stability and lowering systemic toxicity levels. The microbial proteases reduce the likelihood of severe inflammatory conditions since it is an ecologically sustainable and secure therapeutic option. Also, peptides that hold bioactive potential exhibit strong effects on the regulation of immune responses, thereby influencing inflammatory pathways like NF-κB and MAPK. In the area of inflammation, specific bacterial proteases have revealed notable anti-inflammatory traits through changes in immune responses. Such agents possess the capability to attenuate pro-inflammatory cytokines such as TNF-α and IL-1β, thereby impeding leukocyte migration or mitigating the nuclear factor kappa B (NF-κB) signaling pathways, which subsequently alleviates the comprehensive inflammatory cascade. For instance, Serratia sp. synthesizes anti-inflammatory protease such as serratiopeptidase, a class of serine protease noted for its efficacy in degrading fibrin and diminishing inflammation, achieved by disassembling inflammatory exudates and signaling molecules2. Nowadays natural pigments are largely explored because of the lesser environmental toxicity and increased use of synthetic dyes3. Prodigiosin, flexirubin, carotenoids and violacein are some of the important natural pigments derived from bacteria which are increasingly used as an alternative for synthetic dyes due to their extensive applications and stability4. An essential narrative from history is evident in the exploitation of bioactive compounds drawn from bacteria, recognized for their medicinal benefits. In the realm of environmentally sustainable colorants, pigments derived from microorganisms emerge as robust alternatives to synthetic substances. The red pigment prodigiosin exhibits distinctive characteristics, and its synthetic derivatives serve as effective pro-apoptotic agents against diverse cancer cell lines, targeting multiple cellular pathways, including those of multi-drug-resistant cells, while displaying minimal or negligible toxicity towards normal cell lines5. The present study is based on the evaluation of biopotential activity of Serratia sp. CS01, isolated from spoiled coconut, which was used for pigment extraction and characterization. Both the cell free supernatant and pigment sample from bacterial strain exhibited anti-inflammatory, antibacterial and antioxidant properties. The synergistic production of these activities along with pigment production by Serratia sp. CS01 presents promising opportunities for the development of multifunctional bioactive products across the therapeutic and cosmetic domains. Materials and methods Sample collection and isolation Spoiled coconuts were collected and homogenized with 0.85% of sterile saline solution. The sample solutions were serially diluted and plated on to nutrient agar and incubated at 37 °C for 24 h. After the incubation, the red colored bacterial colonies were selected based on their morphological characteristics and maintained on nutrient agar slants at 4 °C6. Identification of CS01 Bacterial culture underwent morphological characterization such as gram staining, Scanning Electron Microscopy (SEM analysis), model- CARL ZEISS EVO 18 research and biochemical characterization, then the results were analyzed in accordance with Bergey’s Manual of Determinative Bacteriology7. By using 16S rDNA sequencing, the potent bacterial species was identified. For the identification, the following primers were used, Forward primer- 27F: 5'-AGAGTTTGATCCTGGCTCAG-3' and Reverse primer- 1492R: 5' TACGGTACCTTGTTACGACTT 3’. The 16 s rRNA sequence was subjected to a BLAST analysis utilizing the NCBI BLAST similarity search tool. Subsequently, a phylogenetic analysis of the query sequence in conjunction with the closely related sequences obtained from the BLAST results was conducted. Multiple sequence alignments were executed with the help of the MUSCLE 3.7 program8. The resultant aligned sequences were refined utilizing the program Gblocks version 0.91b. The program PhyML version 3.0 with aLRT was implemented for phylogenetic analysis, utilizing the HKY85 substitution model9. The sequence of the identified isolate CS01 was deposited into GenBank, National Center for Biotechnology Information (NCBI) and the accession number was obtained as PX533067 (https://www.ncbi.nlm.nih.gov/nuccore/PX533067.1/). Evaluation and characterization of protease activity of CS01 The screening for protease activity for the potent isolate was examined using skimmed milk agar plates10. Following a 24 h incubation period at a temperature of 37 °C, the plates were assessed for the appearance of a hydrolysis zone. The proteolytic activity was determined by using casein as a substrate. The overnight grown culture medium was centrifuged at 8000 rpm for 10 min, and the supernatant was collected. A volume of 0.5 mL supernatant was combined with 2 mL of a 2% casein solution formulated with 0.2 M phosphate buffer (pH 8.0) and was incubated at 37 °C for 30 min. The process was stopped by adding 2.5 mL of 1.2 M trichloroacetic acid (TCA). A control sample (test blank) was prepared by incorporating TCA prior to the enzyme addition. Subsequently, both test and control solutions were filtered using Whatman No. 1 filter paper. To 2.5 mL of the filtrate, 5 mL of 0.4 M Na2CO3 and 0.5 mL of 0.5 N Folin Ciocalteu reagent were added and mixed thoroughly. The absorbance was recorded at 660 nm via a UV–visible spectrophotometer. A unit of protease activity is defined by the enzyme level that yields 1 μmol of tyrosine within a minute at 37 °C11. Employing the Lowry method, the concentrations of protein were quantified in the cell free supernatant sample in relation to Bovine Serum Albumin (BSA) as a standard. All the experiments were carried out in triplicates (n = 3 technical replicates). To identify the presence of anti-inflammatory protease, Shimadzu High-Performance Liquid Chromatography (HPLC) system (LC-20AP, SPD-M20A DAD) was used. The chromatographic conditions for the samples were as follows: column—C18 (4.6 mm × 250 mm, 5 μm); mobile phase—water: methanol (50:50); flow rate—1.2 mL/min; total run time—15 min; injection volume -10 µL; Detection wavelength: 327 nm12. Fourier infrared spectra were determined for Serratia sp. CS01 cell free supernatant as well as the pigment peptide hydrolysates using a Shimadzu, Japan, Thermo Fisher Scientific, USA, Model- IRAffinity-1, Thermo Nicholet iS50 with inbuilt ATR. The IR spectra were obtained at room temperature in the spectral range 4000–500 cm−1. Spectra were analyzed using the same software, and results were exported for plotting using Origin 2025b SR1 10.25.234 software (OriginLab, Northampton, MA, USA)13. Mass spectrometry analyzes were performed using Bruker MALDI-TOF (UltrafleXtreme II). Spectra were analyzed with data Bruker Daltonic MALDI Biotyper and compared to databases from National Center of Biotechnology Information (NCBI). Purification and molecular weight assessment of extracted enzyme Centrifugation was done for the bacterial culture (20 min at 10,000 rpm) and the resultant supernatant was subjected to ammonium sulfate precipitation at saturation levels ranging from 50 to 80%14. The dialysis was done for partial purification process for the precipitated protein by using 20 mM Tris–HCl buffer at 4 °C with the pH 8. The dialyzed sample was further purified through Sephadex G-100 column chromatography, and the fractions were collected15. 12% resolving and 5% stacking gels were used in SDS-PAGE analysis to determine the enzyme’s molecular weight and purity (14). Coomassie Brilliant Blue staining was used for the protein bands visualization along with the use of standard markers to determine the molecular weights. Extraction and characterization of microbial pigment 1 mL CS01 culture, obtained during the exponential growth phase (Log CFU/mL = 5.63), was inoculated into 1 L of nutrient broth media (Himedia®) with the pH calibrated to 7.0. The culture underwent an incubation process lasting 48 h at a stable temperature of 30 °C, at 150 rpm. Overnight grown bacterial broth culture was centrifuged at 10,000 rpm for 10 min. The resultant pellet was collected and subjected to pigment extraction using methanol as a solvent. After the extraction procedure, the solvent was filtered using Whatman No. 1 filter paper to remove the cellular debris and evaporated at 50 °C. The dried pigment was suspended in solvent and evaporated for 2–3 times. The dried pigment was collected and preserved at 4 °C for subsequent characterization16. UV–Vis spectroscopy (200–800 nm) was used to determine the peak absorbance wavelength (λmax) of the pigment for the characterization. To find the functional groups present in the pigments, FTIR spectroscopy was performed. High performance liquid chromatography (HPLC) was carried out for the confirmation of prodigiosin-like pigment identity along with the reference standard prodigiosin from the existing literature. HPLC analyses were performed with an Agilent 1220 Infinity LC fitted with a 4.6 250 mm, 5 m ZORBAX LC column (ZORBAX SB, C18, Agilent). The mobile phase used was a mixture of acidified methanol, water, and acetonitrile in the ratio of 73:20:7, and the detection wavelength was set at 535 nm17. Structural evaluation of the bioactive compounds was performed by using liquid chromatography-high-resolution mass spectrometry (LC-HRMS-ESI). This systematic methodology was carried out utilizing Waters®, USA, Model- XEVO-G2-XS-QTOF mass spectrometer. Extracted pigment sample was dissolved in 1 mg/mL LC–MS grade methanol; finally, 4 μL of extract was injected to carry on the chemical profiling. The LC-HRMS dereplication procedure utilized the LC-HRMS setup fitted with an Acquity UPLC BEH C18 1.7 μm column from Waters. Mobile Phase A in the mobile setup included only LC–MS H2O, and Mobile Phase B was exclusively made of MeCN; both phases were augmented with 0.1% LC–MS formic acid18. Anti-inflammatory assays for extracted protease and pigment samples Human red blood cell membrane stabilization assay Preliminary screening of anti-inflammatory potential was determined by human red blood cell (HRBC) membrane stabilization through single dose concentration19. The study protocol involving human blood samples and all related in vitro assays was reviewed and approved by the Vellore Institute of Technology Institutional Ethics Committee for Human Studies (Approval No: VIT/IECH/2025/16 IECH, dated 15 February 2025). For the preliminary evaluation of anti-inflammatory activity, the experiment was conducted in single dose concentration for which the fresh human blood was collected from a healthy individual, who had not consumed NSAIDs for two weeks. The blood collected was mixed with sterile Alsevier’s solution (2% dextrose, 0.8% sodium citrate, 0.05% citric acid, and 0.42% sodium chloride in distilled water), subjected to centrifugation at 3000 rpm for a span of 10 min, and subsequently washed three times with isotonic saline (0.85%, pH 7.2) to generate a 10% HRBC suspension. The mixture for the assay included 1 mL of phosphate buffer at a concentration of 0.15 M with a pH of 7.4, alongside 2 mL of a hypotonic saline solution that is 0.36%, 0.5 mL of the HRBC suspension, and 0.5 mL of the pigment and the cell free supernatant. In the study, we employed diclofenac sodium as a reference control. After incubation at 37 °C for 30 min, the mixtures were subjected to centrifugation, and the absorbance of the resulting supernatants was evaluated at 560 nm. All the experiments were carried out in triplicates (n = 3 technical replicates). The percentage of protection and the extent of hemolysis were subsequently calculated20. Heat-induced hemolysis assay The samples were mixed with HRBC suspension followed by the incubation at 54 °C for 20 min. The incubated mixture was then centrifuged, and absorbance was measured for the supernatant at a wavelength of 560 nm. Protein denaturation inhibition assay The egg albumin denaturation assay was used to find the anti-inflammatory properties subsequently (8). The reaction mixture was made by using phosphate buffer (pH 6.5), egg albumin solution and protease extract. Then samples were then incubated at 40 °C for an hour, and 70 °C for 5 min. After the incubation the absorbance was measured at 660 nm. Diclofenac was placed as a standard reference. All the experiments were carried out in triplicates (n = 3 technical replicates)20. Antibacterial and antioxidant activities for extracted protease and pigment samples The assessment of antimicrobial activity was performed based on the method described by Berghe and Vlietinck. The agar well diffusion method was performed to determine the antibacterial activity. Cell free supernatant of CS01 and pigment sample were tested against Pseudomonas aeruginosa (MTCC 2582), Escherichia coli (MTCC 443), Bacillus cereus (MTCC 121), and Staphylococcus aureus (MTCC 3160). Muller Hinton (MH) agar plates were swabbed with indicator strains, which were prepared and incubated overnight, wells were bored, and 100 μL of each culture supernatant was loaded. After that, the plates were incubated at 37 °C for 18 h. Ciprofloxacin was used as the antibiotic standard and Nutrient broth served as a negative control21,22. Zones of inhibition were measured. The concentration threshold that inhibits growth (MIC) of prodigiosin-like pigment and cell free supernatant was assessed following the protocols set forth by the Clinical and Laboratory Standards Institute (CLSI, 2010), utilizing the microdilution method in Mueller–Hinton broth. An inoculum at a concentration of 1.5 × 108 CFU/mL was prepared as a suspension using bacterial colonies that had been cultured for a duration of 24 h, standardized to the 0.5 McFarland scale. Cell free supernatant and prodigiosin-like pigment was tested against one gram-positive type (Staphylococcus aureus) and one gram-negative type (Escherichia coli). The antibiotic Ciprofloxacin was used as the standard at a concentration of 2 µg/mL, DMSO was used as solvent control and sterility control was Mueller Hinton Broth. In every 96-well microplate, 100 µL of Mueller–Hinton broth, 10 µL of the standardized bacterial suspension, and 100 µL of test samples (prodigiosin-like pigment ranging from 10 to 150 µg/mL and cell free supernatant ranging from 9.06 to 1000 µg/mL) were dispensed, followed by incubation of the plates at 37 °C for 24 h, after which optical density was measured at 600 nm. The experiment was conducted in triplicates (n = 3 technical replicates). Antibacterial susceptibility test was performed with 3 different antibiotics against Serratia sp. CS01 (Gentamycin, Streptomycin and Ciprofloxacin)23. The antioxidant activity was determined through the DPPH scavenging evaluation24. Ascorbic acid was used as the reference standard. A freshly prepared solution of 0.002% DPPH (2,2-Diphenyl-2-Picryl hydrazyl) dissolved in methanol was added with the test samples (2.0 mL) in triplicates. The samples were kept for incubation in the absence of light at a temperature of 37 °C for 20 min, after which they were assessed at 515 nm. The results were represented as the percentage reduction in absorbance relative to the control. The percentage inhibition of radical scavenging activity was subsequently calculated25. The sample blanks (pigment without cells) were subtracted, and absence of optical interference was also confirmed at the time of experiment. Statistical analysis All experiments were triplicated and GraphPad Prism software (version 9.0.0) was used for statistical analysis for the determination of difference among samples. One-way analysis of variance (ANOVA) was applied for the analysis. When the ANOVA indicated statistical significance (p < 0.05), Tukey’s post hoc test was performed for multiple comparisons to find specific intergroup variances26. Results Screening and determination of protease from potent bacterial strain CS01 A bacterial colony with pinkish-red color was selected, and pure cultures were preserved on nutrient agar plates for other analysis. The isolate was named CS01 and subjected to screening for protease activity by streaking the culture on skim milk agar plates. Proteolytic activity was observed by the development of a clear zone of hydrolysis around the streaks. A maximum zone of hydrolysis (18 mm) was exhibited on secondary screening indicated significant protease activity (Fig. 1 c and d). The total protein and protease activity of the strain were quantitatively evaluated. CS01 showed a maximum protease activity of 54.97 ± 0.01 U/mL and a total protein content of 100.56 ± 0.003 μg/mL (Fig. 2). (a) The contaminated coconut kernel used for bacterial isolation. (b) Pure cultured plate of the bacterial isolate CS01. (c) Protease activity exhibited by CS01 on skim milk agar plate. (d) Radial plate assay for protease screening of CS01 on skim milk agar plate e) Phylogenetic tree constructed using ……..for bacterial isolate CS01. Scanning electron microscope (SEM) image of Serratia sp. CS01. Morphological, biochemical, and molecular level identification of potent bacterial strain CS01 The morphological and biochemical and molecular characterization (16S rDNA) of the strain identified the potent isolate as Serratia sp., a Gram-negative bacterium typically noticed by its red pigmentation (Table 1 and Fig. 1). Table 1Biochemical test results for Serratia sp.Sl. NoTestsResultsGram’s stainingNegative, Rod-shaped1MotilityPositive ( +)2CatalasePositive ( +)3OxidaseNegative ( −)4MRNegative ( −)5VPPositive ( +)6Indole ProductionNegative ( −)7Citrate UtilizationNegative ( −)8UreaseNegative ( −)9Triple sugar ion testK/A, Gas ( +)10Lactose fermentationNegative ( −)11Sucrose fermentationPositive ( +)12Nitrate reductionPositive ( +) Biochemical test results for Serratia sp. For the cell free supernatant sample, a significant broad peak found at 3294 cm−1 pointed to the vibrational characteristics of O–H stretching connected with hydroxyl groups. A peak at 1637 cm−1 corresponded to C = O stretching or conjugated C = C groups that are normally connected with proteins or other conjugated systems. An additional absorption at 654 cm−1 was found associated with alkenes or aromatic structures (Fig. 3). The retention times for both the reference standard and the crude sample were done under identical chromatographic conditions to determine whether the enzyme was present or not. The crude sample showed a distinct peak at a retention time of 5.08 min, closely matching the standard peak found at 5.606 min, thus confirming the presence of an anti-inflammatory protease, since the peak of the crude sample matches with Serratia standard at 327 nm (Fig. 4). FTIR spectra of crude enzyme extracted from Serratia sp. CS01. (a) HPLC chromatogram of Serratiopeptidase standard (b) HPLC chromatogram of crude enzyme sample from Serratia sp. CS01. The trypsin digested protein band derived from Serratia sp. CS01 exhibited various peptide fragments (Fig. 5). A multitude of peptide ions within the mass-to-charge ratio range of 2514.011 to 9507.141 were identified through peptide mass fingerprinting of the excised protein band, with a predominant base peak observed at a mass-to-charge ratio of 2514.011. Various notable peptide ions appeared at 5370.263, 6229.748, 7277.702, 7881.644, and 9507.141. The peptide mass fingerprinting proved that the fragments belonged to the degradation products of anti-inflammatory protease. MALDI-TOF analysis of anti-inflammatory protease fraction from Serratia sp. CS01. Purification and characterization of protease Enzymes from CS01 were partially purified with 70% ammonium sulfate precipitation followed by dialysis and gel chromatography. The molecular weight of the protein produced by Serratia sp.CS01 was determined to be approximately 60 kDa, thereby indicating the presence of an anti-inflammatory protease (Fig. 6). SDS-PAGE analysis of crude and purified enzyme samples. Extraction and characterization of bacterial pigment In the present study a maximum of 1850 mg/L (dry weight) of crude red pigment was extracted from the culture of Serratia sp.CS01. Extraction of bacterial pigment using methanol as a solvent was carried out and the figures are given below (Fig. 7). (a) Contaminated coconut kernel sample. (b) Pure culture plate of Serratia sp. CS01. (c) Pigment production in Nutrient broth. (d) Pellet after centrifugation. (e) Pigment after methanol extraction. (f) Dried pigment sample. The UV–Visible spectrum showed a maximum absorbance peak at 530 nm, suggesting that the pigment belonged to the prodigiosin class of bacterial pigments. For the FTIR characterization, significant peak observed at 3285 cm−1 for the pigment sample which resembles to O–H stretching vibrations, confirming the presence of hydroxyl groups normally found in alcohols or phenolic entities. A peak at 2904 cm11 was found with the C–H stretching signals that indicate the presence of alkanes. An absorption peak observed at 1619 cm−1 represents C = O stretching or C = C stretching vibrations (Fig. 6). Absorption peaks were observed at 1390 cm1, 1054 cm−1 and 545 cm−1 reveals C–H bending, C–O stretching and the existence of out-of-plane bending actions, typically noted in halogenated compounds or aromatic rings (Fig. 8). FTIR spectra of pigment sample extracted from Serratia sp. CS01. When detected with HPLC, peak of the purified pigment at the retention time of 6.766 (Fig. 9) had the almost same retention time 6.252, when compared with existing literature of standard prodigiosin. Detection of purified prodigiosin-like pigment using HPLC. In the high-resolution mass spectrometry (HRMS) analysis, a clear molecular ion peak observed at m/z 324.20 [M + H]+(Fig. 10). High-resolution mass spectrometry (HRMS) analysis of the purified pigment revealed a prominent molecular ion peak at m/z 323.432 [M + H]+. This value closely matched the calculated exact mass for C20H25N3O⁺ corresponding to prodigiosin, with a mass error of − 21.6 ppm. The observed mass accuracy, together with the characteristic molecular ion peak, supports the identification of the extracted pigment as consistent with prodigiosin- like pigment. HRMS analysis of the prodigiosin-like pigment sample. Determining anti-inflammatory activity Based on the HRBC membrane stabilization assay results, the cell free supernatant of Serratia sp. CS01 showed 20.7% hemolysis with 79.3 ± 0.007% stabilization, while the pigment extracted from the isolate exhibited lesser hemolysis (4.67%) and higher stabilization (95.33 ± 0.004%). The standard drug diclofenac showed 15.79% hemolysis with 84.21 ± 0.005% stabilization (Table 2). Table 2Percentage membrane stabilization of human red blood cells by test samples and standard drug under in vitro conditions.SamplesHemolysis (%)Stabilization (%)Serratia sp. CS0120.779.3 ± 0.007Pigment extracted from CS014.6795.33 ± 0.004Diclofenac15.7984.21 ± 0.005 Percentage membrane stabilization of human red blood cells by test samples and standard drug under in vitro conditions. Serratia sp. CS01 exhibited 87.08 ± 0.003% and pigment extracted from CS01 showed 95.27 ± 0.005% protection in thermally stressed condition. The reference drug, Diclofenac, exhibited notable protective effects, showing 94.37 ± 0.003% protection in thermally stressed condition (Fig. 11 a). Tukey’s analysis confirmed that Serratia sp. CS01 had a statistically relevant significance from the pigment sample and diclofenac (p < 0.0001), in contrast, there was no significant difference between the pigment sample and diclofenac (p = 0.4344). This finding suggests that Serratia sp. CS01 demonstrated comparatively diminished activity relative to the other two samples. The anti-inflammatory potential of the isolate and pigment sample was assessed using the egg albumin denaturation assay with diclofenac as a reference standard. Serratia sp. CS01 showed protein denaturation of 80.31 ± 0.01%, Pigment sample showed 85.6 ± 0.005% and diclofenac showed 95.76 ± 0.01% inhibition (Fig. 11 b). Tukey’s test showed statistically significant differences across all sample pairings, with Serratia sp. CS01 exhibiting reduced values in comparison to both the pigment sample (p = 0.0003) and diclofenac (p < 0.0001). Also, the pigment samples result in a prominent reduction in values when compared with diclofenac (p < 0.0001). (a) Percentage of protection (HRBC Membrane) of the crude enzyme sample under heated conditions. (b) Percentage inhibition of protein denaturation by the crude enzyme sample. Antioxidant results Crude and pigment samples from Serratia sp. CS01 showed antioxidant activity of 55.47 ± 0.008% and 91.26 ± 0.006% respectively. In comparison with the samples, ascorbic acid showed 91.33 ± 0.28% of activity. The pigment has similar activity to as shown by ascorbic acid (Table 3). To determine the antioxidant activity of the extract/pigment, we conducted the DPPH free radical scavenging test, adjusting concentrations from 200 to 1000 µg/mL. A concentration-dependent augmentation in radical scavenging efficacy was noted (Table 3). With a concentration of 200 µg/mL, the sample revealed an inhibition rate of 82.34 ± 0.711% in relation to DPPH radicals, which modestly ascended to 82.78 ± 0.53% at the 400 µg/mL dosage. An increase in activity was identified at augmented levels, hitting 85.78 ± 0.58% at 600 µg/mL, 89.45 ± 0.45% at 800 µg/mL, and culminating at 91.26 ± 0.28% at 1000 µg/mL. All tested concentrations revealed scavenging effectiveness over 80%, which underscores a considerable potential for antioxidant properties in the experimental context we used. Given that the lowest concentration examined (200 µg/mL) already yielded an inhibition rate exceeding 50%, the IC₅₀ value could not be interpolated within the concentration range investigated. The DPPH radical scavenging assay showed a concentration-dependent increase in antioxidant activity over the tested range of 200–1000 µg/mL. Linear regression analysis of the mean scavenging values yielded the equation y = 0.012255x + 78.969 with a goodness-of-fit of R2 = 0.9556, indicating a strong positive association between concentration and radical scavenging activity. Data are presented as mean ± SD (n = 3 technical replicates). Table 3Results of radical scavenging activity (%) in DPPH assay, expressed as mean ± SD (n = 3).Concentration of samples (µg/mL)DPPH Scavenging Activity (%)20082.34 ± 0.7140082.78 ± 0.5360085.78 ± 0.5880089.45 ± 0.45100091.26 ± 0.28 Results of radical scavenging activity (%) in DPPH assay, expressed as mean ± SD (n = 3). Antibacterial activity results The cell free supernatant from Serratia sp. CS01 showed antibacterial activity (inhibition zones of 10 mm for Escherichia coli, 12 mm for Bacillus cereus, and 16 mm for Staphylococcus aureus). The pigment extracted from Serratia sp. CS01 showed inhibition against Escherichia coli (18 mm), Bacillus cereus (12 mm) and Staphylococcus aureus (13 mm). Studies indicated the lack of inhibitory zones for both the cell free supernatant and the pigment for Pseudomonas aeruginosa. Here ciprofloxacin served as positive control, with the inhibition zones of roughly 25 mm (Fig. 12). Antibacterial activity of crude samples and pigment extract against pathogenic MTTC bacterial strains. The crude extracts efficacy was tested on Escherichia coli and Staphylococcus aureus through the microbroth dilution approach at diverse concentration levels from 9.06 to 1000 µg/mL. A progressive decrease in optical density was seen alongside the increase in concentration, pointing to a concentration-dependent curtailment of bacterial growth. In the case of Escherichia coli, the percentage of inhibition escalated from 35.17% at 9.06 µg/mL to 79.46% at the maximum concentration of 1000 µg/mL. In terms of inhibition, Staphylococcus aureus showed rates from 46.64% with the least concentration to 76.33% when the highest concentration was tested. The analysis highlights the significant antibacterial attributes of the natural extract towards both Gram-positive and Gram-negative bacterial classifications. The pigment’s antibacterial potential was systematically analyzed against Escherichia coli and Staphylococcus aureus employing the microbroth dilution approach over a spectrum of concentrations from 10 to 150 µg/mL. A concentration-dependent diminution in optical density was documented for both microbial species. Regarding Escherichia coli, the percentage inhibition progressively rose from 74.36% at 10 µg/mL to 89.26% at the 150 µg/mL mark. For Staphylococcus aureus, the inhibition level advanced from 68.63% at 10 µg/mL to 86.93% at the 150 µg/mL mark. The study shows that the pigment possesses noteworthy antibacterial efficacy, even in lower amounts. The MIC determined for both cell free supernatant (9.06–1000 µg/mL) and pigment (10–150 µg/mL) was not reached within the tested concentration. The MIC determination using the resazurin-based 96-well microtiter plate method is shown in the supplementary image. Discussion Anti-inflammatory protease is a proteolytic enzyme that helps reduce inflammation by degrading inflammatory mediators and damaged proteins at the site of inflammation. Microbial proteases can manifest anti-inflammatory characteristics by hydrolyzing fibrin along with various inflammatory agents, which helps lessen swelling and tissue damage27. The current investigation has concentrated on the identification of a robust strain capable of producing an anti-inflammatory protease and prodigiosin-like pigment, which is in considerable demand within various industries28. An examination at the species level using 16S rDNA placed the isolate in the Serratia genus, whereas the phylogenetic study revealed a partial alignment with Serratia rubidaea. The 16S rDNA sequencing is important for recognizing bacterial taxa, yet it may encounter challenges in clearly defining closely related species on occasion. Additional methods, including complete genome are crucial for precise recognition and validation up to species level. Therefore, we have mentioned the Serratia rubidaea as Serratia sp. CS01 throughout the study. Functionally, the isolate exhibited an extracellular protease activity of 54.97 ± 0.01 U/mL, accompanied by a total protein concentration of 100.56 ± 0.003 μg/mL. A significant finding in the present study is that the total protein concentration (100.56 µg/mL) is several orders of magnitude lower than the crude protein levels documented in certain studies of Serratia marcescens screening as approximately 102 mg/mL29. Previous studies have identified strains of Serratia rubidaea producing and secreting proteases that facilitate tissue colonization, which corroborates with our finding that Serratia sp. CS01 as a protease-secreting isolate30. When compared to the prevailing literature concerning serratiopeptidase/serralysin, our recorded activity of 42.15 U/ mL resides within the extensive range documented for wild-type Serratia. For instance, a proteolytic activity of 21.3 U/mL was noted for Serratia marcescens VS56 under specific screening conditions, whereas alternative isolates demonstrated activities ranging from 95 to 156 U/mL; optimized methodologies or recombinant systems have the potential to achieve scales between 103 and 104 U/mL. Variations like these may indicate difference in assay measurements (substrate, unit), culture media, pH/temperature, and the genetic features of the strains. Our activity quantification was conducted under the designated assay conditions such as caseinolytic/HPLC-linked confirmation, and it is vital that direct numerical comparisons are made solely when assay protocols and units are compatible29,31. HPLC validation of the proteolytic enzyme identified as an anti-inflammatory protease was validated by a retention time (RT) of 5.08 min, which closely aligns with that of a standard, measured at 5.606 min. Recent assessments of Serratia isolates have similarly depended on the compatibility of retention times between the sample and the reference standard of serratiopeptidase (e.g., approximately 4.66 ± 0.10 min versus the standard under their experimental conditions) to preliminarily ascertain the identity of the enzyme32. The FT-IR spectrum attained from the cell free supernatant showed significant functional groups, specifically a broad O–H stretching mode at 3294 cm−1, bending vibrational mode at 654 cm−1 and a C = O/C = C stretch vibration at 1637 cm−1. These spectral characteristics indicate the presence of hydroxyl, carbonyl, and unsaturated functional units. In earlier studies, conventional FT-IR analyses of both microbial and plant-derived products containing hydroxyl (O–H), carbonyl (C = O), aliphatic C–H, and aromatic or alkene groups, emphasizing the biochemical diversity. For example, the samples taken from the leaves of Momordica balsamina demonstrated FT-IR peaks that are contained with these functional groups, confirming the nature of their phytochemical properties33. The dominant base peak (m/z 2514.011) with multiple accompanying ions from MS analysis suggests a reproducible protease-related peptide fingerprint, while the additional peaks likely reflect proteolytic processing/autodegradation and co-migrating secreted proteins in the crude extracellular sample34. For further confirmation of anti-inflammatory protease, supplementary confirmatory methodologies (e.g., zymography, peptide mass fingerprinting, immunodetection, or N-terminal sequencing) would be required for definitive identification29. The protease characterized in the current study demonstrated a molecular mass of approximately 60 kDa as established through SDS–PAGE, which aligns with the previously documented molecular weight range of anti -inflammatory protease synthesized by Serratia species. Also, the HPLC assessment showed a retention time of 5.08 min, like the standard serratiopeptidase 5.606 min when subjected to the same chromatographic parameters. These findings imply that the enzyme identified in this investigation may be a protease exhibiting serratiopeptidase-like properties; however, conclusive identification would require sequence-based verification techniques such as LC–MS/MS analysis. Serratiopeptidase is being considered a closer to normal, safer and cheaper substitute to non-steroidal anti-inflammatory drugs (NSAIDs) from a pharmacological perspective35. The different biochemical versatility of serratiopeptidase could allow it to be used in the healing of arthritis, diabetes, cancer as well as in thrombolytic therapy. Serratiopeptidase is a metalloprotease enzyme with a molecular weight from 45 to 60 kDa. It contains zinc in its active site. Serratiopeptidase belongs to the serralysin family, and 3.4.24.40 is the Enzyme Commission (EC) number assigned36. The enzyme consists of 470 amino acids which play an important role in the proteolytic activity of the enzyme. Interestingly, the enzyme does not contain sulfur amino acids, i.e., cysteine and methionine. Serratiopeptidase has the highest enzymatic activity at pH 9 and a temperature of 40 °C and can thus be inactivated by exposure at 55° C for 15 min37. Whereas the red pigmented prodigiosin comprise a distinct molecular configuration called pyrrolylpyrromethane and are sourced from Serratia marcescens. This pigment denotes hopeful aspects, incorporating antifungal, immunosuppressive, and antiproliferative abilities. It is believed that prodigiosin may provide a natural substitute for synthetic colorants in future food industry. This pigment has been shown to induce apoptosis across various cancer cell lines, encompassing acute human T-cell leukemia, promyelocytic leukemia, human and rat hepatocellular carcinoma, human breast cancer, and TNF-stimulated human cervical carcinoma. The peculiar significance of apoptotic procedures has been correlated with the apoptosis caused by cycloprodigiosin38. The prodigiosin-like pigment extracted from Serratia sp. CS01 showed an absorbance at 530 nm in UV–Visible spectrophotometry, which closely relates with the peaks of prodigiosin, typically ranging from 532 to 536 nm subject to pH and solvent conditions. For example, Arivizhivendhan et al., documented an absorption peak at 532 nm, whereas da Silva et al., indicated a maximum at 535 nm for prodigiosin in UV–Visible spectrophotometer39. The FT-IR spectrum for pigment sample revealed an extensive absorption peak at 3285 cm−1, which signifies the stretching vibrations of hydroxyl (O–H), plus a peak at 2904 cm−1 associated with alkane C–H stretching patterns. A prominent absorption observed at 1619 cm−1 is suggestive of carbonyl/conjugated double-bond (C = O/C = C) stretching, while supplementary peaks at 1390 cm−1 and 1054 cm−1 correspond to C–H bending and C–O stretching associated with ester or ether functional groups. Also, a somewhat weaker peak at 545 cm−1 indicates bending that occurs out of the plane, a feature that is regularly encountered in aromatic rings that have substitutions or in organic compounds that are halogenated. The functional groups detailed here correspond with earlier recorded FT-IR spectra of prodigiosin. For instance, Faraag et al., reported spectral peaks at 3423–3424 cm−1, characteristic of –N–H or O–H stretching vibrations, 2920–2922 cm−1 indicative of C–H stretching, prominent bands in the vicinity of 1600–1630 cm−1 corresponding to aromatic C = C or –NH, and features ranging from 1119–1067 cm−1 associated with C–O stretching, which exhibit comparability to the signals observed in our extract40. Furthermore, recent literature substantiates that UV absorbance at approximately 535 nm, in association with the presence of these FT-IR bands, serves as a reliable indicator of prodigiosin-like pigment identity41. In summary, the results from UV–Vis and FT-IR evaluations convincingly affirm the principle that the pigment obtained from Serratia sp. CS01 does in fact indicate a prodigiosin- like material. A peak at m/z 324.20 in the HRMS analysis corresponds with the protonated variant [M + H] + of prodigiosin, showing a calculated mass of 323.432 Da. This observation was validated by mass spectrometric identification of prodigiosin in Serratia marcescens and other bacterial species, wherein analogous m/z ≈ 324 peaks confirmed the presence of prodigiosin-like pigment. A study by Lin et al., shows that in HPLC, purified pigment has the largest peak at a retention time of 6.254 min, almost matches with the retention time of 6.766 min of the pigment from Serratia sp. CS0142. The protease enzyme exerts anti-inflammatory effects through its proteolytic degradation of inflammatory exudates, fibrin, and necrotic tissue, thereby improving microcirculation and tissue permeability. Additionally, serratiopeptidase reduces edema and pain by lowering bradykinin levels and inhibiting neutrophil migration, contributing to accelerated resolution of inflammation. Prodigiosin exhibits anti-inflammatory activity by modulating redox-sensitive signaling pathways, particularly through inhibition of NF-κB activation and subsequent downregulation of pro-inflammatory mediators such as TNF-α, IL-1β, IL-6, COX-2, and iNOS. By reducing intracellular reactive oxygen species, prodigiosin attenuates oxidative stress-induced inflammatory cascades and limits leukocyte-mediated tissue damage43. The HRBC membrane-stabilization assay exhibited that the pigment isolated from Serratia sp. CS01 showed higher stabilization (95.33 ± 0.004%) compared to both the cell free supernatant (79.3 ± 0.007%) and the reference drug diclofenac (84.21 ± 0.005%). Previous investigations have verified significant, dose-dependent HRBC protection conferred by the anti-inflammatory potential of crude S. marcescens VS56 was 94.6% equivalent to the standard diclofenac (94.6%)29. Although several studies documented that HRBC protection provided by diclofenac will vary upon concentration, incubation parameters, and the specific hemolysis trigger employed44. This study focused on single dose concentration towards preliminary analysis rather than multiple concentrations. The heat-induced hemolysis method was used to measure the capability to stabilize red blood cell membranes under thermal stress. Serratia sp. CS01 exhibited a notable protection (87.08 ± 0.003%) in thermally stressed samples and in non-thermally stressed samples (79.3 ± 0.007%), thereby indicating strong membrane stabilization. The pigment extracted sample exhibited 95.27 ± 0.005% protection in thermally stressed samples and 95.33 ± 0.004% protection in non-thermally stressed samples. The reference drug, diclofenac showed providing 94.37 ± 0.003% protection in thermally stressed conditions. Previous studies suggested that pigment fractions from microbial and botanical sources indicated stronger anti-inflammatory potential due to their concentrated bioactive ingredients also the pigments like prodigiosin and violacein produced by microbes demonstrate strong membrane stabilization45. In terms of protein denaturation, Serratia sp. CS01 showed significant anti-inflammatory potential (85.6 ± 0.005%) through the inhibition of albumin denaturation and diclofenac showed 95.76 ± 0.01%. Antioxidant activity is interpreted based on redox-active functional groups, free radical scavenging ability, and indirect reduction of oxidative stress through removal of damaged proteins and inflammatory mediators. The conjugated tripyrrole system of production stabilizes free radicals by distributing unpaired electrons, and its ability to chelate metals helps to prevent the formation of ROS catalyzed by metals. Altogether, these pathways lessen oxidative stress and help in safeguarding cellular biomolecules against oxidative damage5. Serratia sp. CS01 exhibited an antioxidant activity of 55.93 ± 0.008% and the pigment extracted from Serratia sp. CS01 showed the activity of 91.26 ± 0.28% respectively. The reference standard, ascorbic acid, exhibited higher activity, thereby indicating the moderate antioxidant property of CS01 and better activity for the pigment sample. In a previous study, prodigiosin extracted from Serratia marcescens, shows quantifiable antioxidant efficacy as 22.05 μg ascorbic acid equivalents per mL of extract, highlighting its important radical-scavenging properties46. In the present study, all evaluated concentrations demonstrated significant DPPH radical scavenging activity, with inhibition percentages surpassing 80%, thereby indicating a remarkable antioxidant potential of the sample under the specified experimental conditions. As the least concentration tested (200 µg/mL) caused an inhibition above 50%, it was impossible to pinpoint the IC₅₀ value precisely in the range of concentrations being examined. This finding implies that the antioxidant activity of the sample is relatively strong, necessitating future investigations that involve lower concentration ranges to accurately ascertain the IC₅₀ value and further elucidate its antioxidant efficacy. Antibacterial activity showed inhibition of 10 mm against Escherichia coli, 12 mm for Bacillus cereus, and 16 mm for Staphylococcus aureus, highlighting the Serratia sp. CS01 cell free supernatant’s moderate antibacterial property. The pigment sample showed inhibition zones for Escherichia coli (18 mm) and Bacillus cereus (12 mm) and no inhibition zone was exhibited against Staphylococcus aureus or Pseudomonas aeruginosa. The antibacterial efficacy uncovered that both the pigment and the cell free supernatant showed concentration-dependent inhibition against Escherichia coli and Staphylococcus aureus. Nevertheless, the pigment exhibited a significantly greater antibacterial efficacy in comparison to the crude extract, attaining inhibition rates nearing 90% within a concentration spectrum (10–150 µg/mL), while the crude extract showed only moderate inhibition even at elevated concentrations (up to 1000 µg/mL). As complete inhibition was not observed within the tested concentrations, the MIC was considered not achieved. However, the pigment showed better antibacterial activity than the crude extract. These results underscore that the bioactive pigment markedly enhances antimicrobial efficacy and emphasize the necessity for further fractionation, elevated concentration assessments, and mechanistic investigations to accurately ascertain the MIC and elucidate the mode of action. Prodigiosin showcases antibacterial activity as it can move through the outer membrane and later impede essential target enzymes, including DNA gyrase and topoisomerase IV, thereby preventing cellular growth. Compared to earlier studies by Vora et al., observed prodigiosin derived from Serratia marcescens, showing inhibition zones of 12 mm (Bacillus cereus), 7 mm (Staphylococcus aureus), and 6 mm (Escherichia coli), like our results for Bacillus cereus and Escherichia coli; nevertheless, our pigment showed increased activity47. These results interpret that prodigiosin-like pigment is effective against bacteria, targeting both Gram-positive and Gram-negative strains. Limitations of the study The study is limited by the absence in evaluation at multiple concentrations of crude enzyme to establish dose–response relationships and provide a more comprehensive assessment of the anti-inflammatory potential. Purification of crude enzyme is essential for understanding the nature of protease that provides the anti-inflammatory activity. The bioactivity of purified enzyme and pigment fractions will be studied in the near future. Also, the 16S rDNA sequencing alone was insufficient for definitive species-level identification. Hence, a species and strain level identification of Serratia sp. CS01 requires whole genome sequencing or MALDI-TOF MS. Moreover, WGS could also provide information about the functional genome of the organism considering its bioactivity. Conclusion The present study reveals that Serratia sp. CS01 is a bacterial strain having bioactive potential including anti-inflammatory, antioxidant and anti-bacterial properties. The substantial proteolytic activity was confirmed along with the synthesis of anti-inflammatory protease (~ 60 kDa). Serratia sp. CS01 can produce prodigiosin-like pigment, a bacterial pigment which was verified by UV–Vis, FTIR, and HRMS analysis. By analyzing these results, we can conclude that Serratia sp. CS01 is a versatile strain, having potential to be included in therapeutic and cosmetic industries. Future research should focus on the biosynthesis of anti-inflammatory protease and prodigiosin in large scale with respect to the determination of its clinical efficacy and risk profile through in vivo studies. Supplementary Information Below is the link to the electronic supplementary material. Supplementary Material 1 Supplementary Material 2 Acknowledgements We would like to thank Vellore Institute of Technology for providing us with the required facilities to pursue this research. Author contributions A.A.K and A.S has done the Experiments, Analysis, Interpretation of data, Writing and Editing Original Draft; N.K.S, P.S.S and B.R.A has carried out part of experiment and wrote the methodology; S.D.C, R.K and S.D.V has carried out the Data Curation and Formal analysis; M.V Designed the work and carried out Supervision, Validation, Writing original draft and Editing. Funding Open access funding provided by Vellore Institute of Technology. No funding was received for conducting this study. Data availability The datasets generated and analysed during the current study are available in the name of Mohanasrinivasan V repository, under the GenBank accession number PX533067 and can be accessed through the following link https://www.ncbi.nlm.nih.gov/nuccore/PX533067.1/ Declarations Competing interests The authors declare that they have no conflict of interest in the publication. Ethical approval The study protocol involving human blood samples and all related in vitro assays was reviewed and approved by the Vellore Institute of Technology Institutional Ethics Committee for Human Studies (Approval No: VIT/IECH/2025/16 IECH, dated 15 February 2025). This study was performed in line with the principles of the Declaration of Helsinki. Informed consent was obtained from all individual participants included in the study. Consent for publication Not applicable. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement The datasets generated and analysed during the current study are available in the name of Mohanasrinivasan V repository, under the GenBank accession number PX533067 and can be accessed through the following link https://www.ncbi.nlm.nih.gov/nuccore/PX533067.1/